Department of Pharmacognosy, Biotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, (MUMS), P.O. Box: 91775-1365, Mashhad, Iran.
Phytomedicine. 2010 Mar;17(3-4):269-73. doi: 10.1016/j.phymed.2009.05.020. Epub 2009 Jul 3.
A prenylated coumarin (diversin, 1) together with four new sesquiterpene lactones (diversolides A, D, F and G, 2-5) isolated from the roots of Ferula diversivittata were studied for their possible inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA). All of the tested compounds were active against EBV-EA activation. Among these compounds diversin (IC(50): 7.7) exhibited the strongest inhibitory effect and was selected to examine its effects on in vivo two-stage mouse skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene (DMBA) as initiator and TPA as promoter. Treatment with compound 1 (85nmol) along with DMBA/TPA inhibited papilloma formation up to week 7 and the percentage of papilloma bearers was approximately 93.3% at week 20. The average number of papillomas formed per mouse was only 5.5 even at week 20. The results of the present investigation indicated that diversin might be valuable as a potent cancer chemopreventive agent and its potency was comparable with those of curcumin and quercetin, two well-known cancer chemopreventive agents.
从多裂阿魏根部分离得到的一个烯丙基香豆素(歧化化合物 1)和四个新的倍半萜内酯(歧化内酯 A、D、F 和 G,2-5),研究了它们对 12-O-十四烷酰佛波醇-13-乙酸酯(TPA)诱导的 Epstein-Barr 病毒早期抗原(EBV-EA)激活的可能抑制作用。所有测试的化合物都对 EBV-EA 激活具有活性。在这些化合物中,歧化化合物 1(IC50:7.7)表现出最强的抑制作用,并被选择用于研究其对 7,12-二甲基苯并[a]蒽(DMBA)作为引发剂和 TPA 作为促进剂诱导的体内两阶段小鼠皮肤致癌作用的影响。用化合物 1(85nmol)与 DMBA/TPA 一起处理,可抑制直至第 7 周的乳头瘤形成,第 20 周时的乳头瘤携带者百分比约为 93.3%。即使在第 20 周,每只小鼠形成的乳头瘤平均数量也仅为 5.5。本研究结果表明,歧化化合物 1 可能是一种有价值的强效癌症化学预防剂,其效力可与两种著名的癌症化学预防剂姜黄素和槲皮素相媲美。